Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma—A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial.
Saved in:
| Title: | Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma—A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial. |
|---|---|
| Authors: | Joffe, Erel1,2,3 (AUTHOR) erelj@tlvmc.gov.il, Kumar, Anita1,2 (AUTHOR), Tuscano, Joseph M.3,4 (AUTHOR), Moskowitz, Alison J.1,2,4 (AUTHOR), Owens, Colette1,5 (AUTHOR), Noy, Ariela1,2,6 (AUTHOR), Palomba, Maria Lia1,2,7 (AUTHOR), Zelenetz, Andrew D.1,2 (AUTHOR), Ni, Andy1,2,5 (AUTHOR), Sharon, Elad3,6,7 (AUTHOR), Vardhana, Santosha1,2,4 (AUTHOR) |
| Source: | Cancers. Jan2026, Vol. 18 Issue 2, p284. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18020284 |
